Epigral: Board Meeting Intimation for Consider And Approval Of Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The ThirdQuarter And Nine Months Ended On 31St December 2025.

Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Third Quarter and Nine Months ended on 31st December 2025.